EP0101554A2 — New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
Assigned to Lehner AG · Expires 1984-02-29 · 42y expired
What this patent protects
Derivatives of biliary acids having formula I wherein St has the meaning of the 17-etiocholanyl residue, having two or more hydroxyl groups both in the a and β conformation, some of which being optionally replaced by keto groups, and their pharmaceutically acceptable salts w…
USPTO Abstract
Derivatives of biliary acids having formula I wherein St has the meaning of the 17-etiocholanyl residue, having two or more hydroxyl groups both in the a and β conformation, some of which being optionally replaced by keto groups, and their pharmaceutically acceptable salts with alkaline or alkali-earth metals, or with organic bases.
Drugs covered by this patent
- Ocaliva (OBETICHOLIC ACID) · Intercept Pharms Inc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.